315 related articles for article (PubMed ID: 31385465)
41. The epidemiology of hepatitis B and hepatitis C infections in China from 2004 to 2014: An observational population-based study.
Liu Z; Yang Q; Shi O; Ye W; Chen X; Zhang T
J Viral Hepat; 2018 Dec; 25(12):1543-1554. PubMed ID: 29851287
[TBL] [Abstract][Full Text] [Related]
42. Burden of disease related to hepatitis C and hepatitis B in Spain: a methodological challenge of an unfolding health problem.
García-Fulgueiras A; García-Pina R; Morant C; de Larrea-Baz NF; Alvarez E
J Viral Hepat; 2011 Oct; 18(10):e453-60. PubMed ID: 21914063
[TBL] [Abstract][Full Text] [Related]
43. Secular Trends of Acute Viral Hepatitis Incidence and Mortality in China, 1990 to 2019 and Its Prediction to 2030: The Global Burden of Disease Study 2019.
Su X; Zheng L; Zhang H; Shen T; Liu Y; Hu X
Front Med (Lausanne); 2022; 9():842088. PubMed ID: 35360747
[TBL] [Abstract][Full Text] [Related]
44. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013.
Beste LA; Leipertz SL; Green PK; Dominitz JA; Ross D; Ioannou GN
Gastroenterology; 2015 Nov; 149(6):1471-1482.e5; quiz e17-8. PubMed ID: 26255044
[TBL] [Abstract][Full Text] [Related]
45. Nonalcoholic fatty liver disease burden: Australia, 2019-2030.
Adams LA; Roberts SK; Strasser SI; Mahady SE; Powell E; Estes C; Razavi H; George J
J Gastroenterol Hepatol; 2020 Sep; 35(9):1628-1635. PubMed ID: 32048317
[TBL] [Abstract][Full Text] [Related]
46. Changing epidemiology of hepatocellular carcinoma in Asia.
Goh GB; Chang PE; Tan CK
Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):919-28. PubMed ID: 26651253
[TBL] [Abstract][Full Text] [Related]
47. Variations in incidence and mortality rates of endometrial cancer at the global, regional, and national levels, 1990-2019.
Gu B; Shang X; Yan M; Li X; Wang W; Wang Q; Zhang C
Gynecol Oncol; 2021 May; 161(2):573-580. PubMed ID: 33551200
[TBL] [Abstract][Full Text] [Related]
48. [Changing trends in etiologies of hospitalized patients with liver disease during 2006 -2014].
Liu B; Zhang YX; Zhang WH; Han YP; Li J
Zhonghua Gan Zang Bing Za Zhi; 2018 Jun; 26(6):446-450. PubMed ID: 30317759
[No Abstract] [Full Text] [Related]
49. Mortality rates among individuals diagnosed with hepatitis C virus (HCV); an observational cohort study, England, 2008 to 2016.
Ireland G; Mandal S; Hickman M; Ramsay M; Harris R; Simmons R
Euro Surveill; 2019 Jul; 24(30):. PubMed ID: 31362807
[TBL] [Abstract][Full Text] [Related]
50. Long-term trends in incidence, mortality and burden of liver cancer due to specific etiologies in Hubei Province.
Liu H; Li J; Zhu S; Zhang X; Zhang F; Zhang X; Zhao G; Zhu W; Zhou F
Sci Rep; 2024 Feb; 14(1):4924. PubMed ID: 38418596
[TBL] [Abstract][Full Text] [Related]
51. Global burden of liver cancer in males and females: Changing etiological basis and the growing contribution of NASH.
Tan DJH; Setiawan VW; Ng CH; Lim WH; Muthiah MD; Tan EX; Dan YY; Roberts LR; Loomba R; Huang DQ
Hepatology; 2023 Apr; 77(4):1150-1163. PubMed ID: 36037274
[TBL] [Abstract][Full Text] [Related]
52. Mortality trends among people with hepatitis B and C: a population-based linkage study, 1993-2012.
Alavi M; Grebely J; Hajarizadeh B; Amin J; Larney S; Law MG; George J; Degenhardt L; Dore GJ
BMC Infect Dis; 2018 May; 18(1):215. PubMed ID: 29743015
[TBL] [Abstract][Full Text] [Related]
53. Risk factors for the rising rates of primary liver cancer in the United States.
El-Serag HB; Mason AC
Arch Intern Med; 2000 Nov; 160(21):3227-30. PubMed ID: 11088082
[TBL] [Abstract][Full Text] [Related]
54. Epidemiological Trends in Gastrointestinal Cancers in China: An Ecological Study.
Xi L; Zhu J; Zhang H; Muktiali M; Xu C; Wu A
Dig Dis Sci; 2019 Feb; 64(2):532-543. PubMed ID: 30350242
[TBL] [Abstract][Full Text] [Related]
55. [Analysis and prediction of burden of viral hepatitis C-associated diseases in China from 1990 to 2044].
Zhou M; Yao L; Wu Y; Lin S; Huang J
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2023 Dec; 35(5):476-485. PubMed ID: 38148536
[TBL] [Abstract][Full Text] [Related]
56. Trends of hepatitis B and hepatitis C mortality in Canada, 1979-1997.
Pohani G; Zou S; Tepper M
Can J Public Health; 2001; 92(4):250-4. PubMed ID: 11962107
[TBL] [Abstract][Full Text] [Related]
57. Temporal trends in disease presentation and survival of patients with hepatocellular carcinoma: A real-world experience from 1998 to 2015.
Kim NG; Nguyen PP; Dang H; Kumari R; Garcia G; Esquivel CO; Nguyen MH
Cancer; 2018 Jun; 124(12):2588-2598. PubMed ID: 29624631
[TBL] [Abstract][Full Text] [Related]
58. Secular trends of morbidity and mortality of prostate, bladder, and kidney cancers in China, 1990 to 2019 and their predictions to 2030.
Huang Q; Zi H; Luo L; Li X; Zhu C; Zeng X
BMC Cancer; 2022 Nov; 22(1):1164. PubMed ID: 36368976
[TBL] [Abstract][Full Text] [Related]
59. [Global liver cancer incidence and mortality and future trends from 2000 to 2020: GLOBOCAN data analysis].
Wang RH; Hu M; Yang ZY; Niu ZY; Chen HS; Zhou X; Cao GW
Zhonghua Gan Zang Bing Za Zhi; 2023 Mar; 31(3):271-280. PubMed ID: 37137853
[No Abstract] [Full Text] [Related]
60. [Primary prevention by hepatitis B vaccine on liver cancer in high incidence area of China].
Wang YT; Chen TY; Zhu J; Jiao YC; Qu CF
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Apr; 52(4):402-408. PubMed ID: 29614608
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
